LITIGATOR IN THE SPOTLIGHT

After Bratz doll maker MGA Entertainment, Inc., lost a 2008 copyright and trademark infringement trial to Mattel, Inc., the U.S. district court in Riverside, California, awarded Mattel the Bratz franchise. MGA looked doomed. But in December, MGA appellate counsel E. Joshua Rosenkranz of Orrick, Herrington & Sutcliffe (pictured here) convinced the U.S. Court of Appeals for the Ninth Circuit to stay the injunction, arguing that the doll designer’s Mattel employment contract was ambiguous at best. In July the court overturned the injunction entirely and wiped out $100 million in damages. A new trial is set for January. –AF


DEALMAKER IN THE SPOTLIGHT

Peter Samuels of Proskauer Rose led the legal team advising Barcelona-based Grifols, S.A., in its $3.4 billion acquisition of North Carolina–based Talecris Biotherapeutics Holdings Corp. in June. The two companies are a near-perfect fit, says Samuels, cochair of his firm’s M&A group: Each brings different manufacturing strengths to the blood plasma products industry, as well as complementary geographic reach. Because of the anticipated operational and cost-savings benefits of the merger, Samuels says his client could afford to pay a 53 percent premium for Talecris. Last year the Federal Trade Commission blocked the proposed acquisition of Talecris by an Australian biotechnology company, CSL Ltd., on antitrust grounds, but Samuels says this deal is a different case. “We’re optimistic about a positive outcome with this transaction,” he says. –TB